Combination comprising parthenolide for use in the treatment of alzheimer's disease and other neurodegenerative disorders
Patent StatusPublished Application
Permanent link to this recordhttp://hdl.handle.net/10754/630898
MetadataShow full item record
AbstractThe present invention generally concerns particular methods and compositions for treatment of a neurodegenerative disease, such as Alzheimer's Disease. In particular embodiments, there is a composition comprising Parthenolide and a second agent, including an inhibitor of TLR4/MD-2/CD14, nAChR agonist, Resatorvid, Curcumin, Tilorone or a Tilorone analog, or a combination thereof.